The third annual Vanderbilt Alzheimer’s Disease Research Day featured numerous presentations and concluded with a keynote address by Suzanne Craft, PhD, director of the Alzheimer’s Disease Research Center at Wake Forest University.

The Vanderbilt Center for Tourette Syndrome and Other Tic Disorders has been designated a Tourette Association of America (TAA) Center of Excellence.

A folic acid-like drug changed a DNA process within brain tumors of glioblastoma patients, according to results from a phase 1 clinical trial.

A study by Vanderbilt researchers sheds light on how current antidepressant drugs work and suggests a new drug target in depression.

An international phenomenon of involuntary movements and vocalizations in adolescent girls is now believed to be a functional movement disorder, and while the causes are unclear, TikTok and other social medial platforms may be important contributors.

Neuro-oncologist Ryan Merrell, MD, has joined Vanderbilt University Medical Center as chief of the Division of Neuro-Oncology in the Department of Neurology.

Sending survey tools to epilepsy patients before their clinic appointment doubled the numbers of patients who were diagnosed and treated for depression and anxiety disorders, Vanderbilt neurologists found.